- Home
- BOLT vs KAPA Comparison
BOLT vs KAPA Comparison
Compare BOLT & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- KAPA
- Stock Information
- Founded
- BOLT 2015
- KAPA 2013
- Country
- BOLT United States
- KAPA United States
- Employees
- BOLT N/A
- KAPA N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- KAPA
- Sector
- BOLT Health Care
- KAPA
- Exchange
- BOLT Nasdaq
- KAPA NYSE
- Market Cap
- BOLT 22.6M
- KAPA 19.9M
- IPO Year
- BOLT 2021
- KAPA 2024
- Fundamental
- Price
- BOLT $0.51
- KAPA $1.73
- Analyst Decision
- BOLT Hold
- KAPA Strong Buy
- Analyst Count
- BOLT 5
- KAPA 1
- Target Price
- BOLT $1.25
- KAPA $9.00
- AVG Volume (30 Days)
- BOLT 186.2K
- KAPA 6.1M
- Earning Date
- BOLT 11-12-2024
- KAPA 02-23-2025
- Dividend Yield
- BOLT N/A
- KAPA N/A
- EPS Growth
- BOLT N/A
- KAPA N/A
- EPS
- BOLT N/A
- KAPA N/A
- Revenue
- BOLT $9,779,000.00
- KAPA N/A
- Revenue This Year
- BOLT $9.87
- KAPA N/A
- Revenue Next Year
- BOLT N/A
- KAPA N/A
- P/E Ratio
- BOLT N/A
- KAPA N/A
- Revenue Growth
- BOLT 35.86
- KAPA N/A
- 52 Week Low
- BOLT $0.48
- KAPA $0.85
- 52 Week High
- BOLT $1.56
- KAPA $4.00
- Technical
- Relative Strength Index (RSI)
- BOLT 41.39
- KAPA N/A
- Support Level
- BOLT $0.50
- KAPA N/A
- Resistance Level
- BOLT $0.55
- KAPA N/A
- Average True Range (ATR)
- BOLT 0.04
- KAPA 0.00
- MACD
- BOLT -0.00
- KAPA 0.00
- Stochastic Oscillator
- BOLT 13.04
- KAPA 0.00
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.